Form D Explorer

Form D — SRT Therapeutics, Inc.

0002080322-25-000008 · filed Aug 14, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$47,510,731
Reported amount sold
$47,399,588
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
SRT Therapeutics, Inc.
CIK
2080322
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2024
Address
5601 Oberlin Drive, Suite 100
San Diego, CA 92121
Phone
(858) 868-7108

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗